Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Forecasted Growth Rate and Market Size of the Vaccine Adjuvants Market?
The market for mRNA cancer vaccines and therapeutics has expanded significantly in the past few years. The market size is forecasted to rise from $61.52 billion in 2024 to $71.22 billion in 2025, displaying a compound annual growth rate (CAGR) of 15.8%. Factors such as changes in lifestyles, financial backing, supportive regulatory conditions, robust healthcare infrastructure, and the growth in pipeline development have contributed to this growth in the historical period.
In the ensuing years, the market size of mRNA cancer vaccines and therapeutics is predicted to witness a swift expansion. It is anticipated to escalate to “$125.56 billion by 2029, recording a compound annual growth rate (CAGR) of 15.2%. Factors contributing to this surge during the forecast duration comprise encouraging outcomes of clinical trials, increasing consciousness and adoption of mRNA technology, unfulfilled medical requirements in cancer cure, possibility for better patient results, and potential for mainstream availability. Key trends during this period entail broadening into new curative zones, personalized treatment methodology, progress in mRNA delivery frameworks, multivalent mRNA vaccines, and the utilization of artificial intelligence and machine learning in mRNA design.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
Which Factor Is Shaping The Future Of The Vaccine Adjuvants Market?
The escalating frequency of infectious diseases has the potential to boost the growth of the vaccine adjuvants market in the future. These diseases, induced by viruses, bacteria, fungi, or parasites, are treated with immunizations for conditions like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. To illustrate, the 2022 report from the World Health Organization (WHO) revealed that there were around 10.6 million global tuberculosis cases in 2021, resulting in 1.6 million deaths. Moreover, in the same year, 1.5 million people contracted HIV, and 650,000 people succumbed to the disease. Therefore, the increasing occurrence of infectious diseases will enhance the growth of the vaccine adjuvants market.
The mrna cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
What Upcoming Trends Are Expected To Impact The Vaccine Adjuvants Market Globally?
Leading companies in the mRNA cancer vaccine and therapeutic market are concentrating their efforts on creating groundbreaking treatments like mRNA cancer vaccines, with the aim of increasing effectiveness, improving patient outcomes, and satisfying the urgent need for efficient cancer therapies. mRNA cancer vaccines are a particular kind of immunotherapy that employs messenger RNA to direct cells in producing specified antigens, which triggers the immune system to identify and eradicate cancer cells. As an example, WestGene Biopharma, a biotech firm based in China, earned FDA acceptance for its new drug application of the mRNA therapeutic cancer vaccine, WGc-043, in May 2024. The FDA’s endorsement of WGc-043 signifies a major achievement in the treatment of advanced EB virus-related cancers, which are heavily associated with more than ten types of cancer, including nasopharyngeal carcinoma, NK T-cell lymphoma, and cancers of the stomach, lungs, liver, esophagus, breast, and cervix, as well as autoimmune diseases like multiple sclerosis and lupus.
Which Companies Hold The Largest Market Share In The Vaccine Adjuvants Sector?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
How Does Regional Performance Compare Across The Vaccine Adjuvants Industry?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
